{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:43Z","timestamp":1793275363688,"version":"4.5.0"},"reference-count":50,"publisher":"Society for Neuroscience","issue":"41","license":[{"start":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T00:00:00Z","timestamp":1239148800000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"published-print":{"date-parts":[[2008,10,8]]},"abstract":"<jats:p>Recent studies suggest that subtype-selective activators of M<jats:sub>1<\/jats:sub>\/M<jats:sub>4<\/jats:sub>muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms associated with schizophrenia and Alzheimer's disease. Previously developed muscarinic agonists have provided clinical data in support of this hypothesis, but failed in clinical development because of a lack of true subtype specificity and adverse effects associated with activation of other mAChR subtypes. We now report characterization of a novel highly selective agonist for the M<jats:sub>1<\/jats:sub>receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-(1\u2032-2-methylbenzyl)-1,4\u2032-bipiperidin-4-yl)-1<jats:italic>H<\/jats:italic>-benzo[<jats:italic>d<\/jats:italic>]imidazol-2(3<jats:italic>H<\/jats:italic>)-one]. Mutagenesis and molecular pharmacology studies revealed that TBPB activates M<jats:sub>1<\/jats:sub>through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely critical for its unprecedented selectivity. Whole-cell patch-clamp recordings demonstrated that activation of M<jats:sub>1<\/jats:sub>by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M<jats:sub>2<\/jats:sub>and M<jats:sub>4<\/jats:sub>. TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists. Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased A\u03b2 production<jats:italic>in vitro<\/jats:italic>. Together, these data suggest that selective activation of M<jats:sub>1<\/jats:sub>may provide a novel approach for the treatment of symptoms associated with schizophrenia and Alzheimer's disease.<\/jats:p>","DOI":"10.1523\/jneurosci.1850-08.2008","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T16:33:03Z","timestamp":1223483583000},"page":"10422-10433","source":"Crossref","is-referenced-by-count":214,"title":["Novel Selective Allosteric Activator of the M<sub>1<\/sub>Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats"],"prefix":"10.1523","volume":"28","author":[{"given":"Carrie K.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Noor","family":"Tantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Phillip","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania R.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sib","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel Y.","family":"Deutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Jeffrey","family":"Conn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2008,10,8]]},"reference":[{"key":"2023041303342861000_28.41.10422.1","doi-asserted-by":"publisher","DOI":"10.1038\/nn992"},{"key":"2023041303342861000_28.41.10422.2","first-page":"159P","article-title":"Comparison of three [18F]fallypride methods intended for automated remote chemistry modules","volume":"47","author":"Ansari","year":"2006","journal-title":"J Nucl Med"},{"key":"2023041303342861000_28.41.10422.3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550160091022"},{"key":"2023041303342861000_28.41.10422.4","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199703000-00004"},{"key":"2023041303342861000_28.41.10422.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.3037705"},{"key":"2023041303342861000_28.41.10422.6","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(88)90190-0"},{"key":"2023041303342861000_28.41.10422.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.01903.x"},{"key":"2023041303342861000_28.41.10422.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00267-4"},{"key":"2023041303342861000_28.41.10422.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.01.020"},{"key":"2023041303342861000_28.41.10422.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrd746"},{"key":"2023041303342861000_28.41.10422.11","doi-asserted-by":"publisher","DOI":"10.2174\/1568007024606212"},{"key":"2023041303342861000_28.41.10422.12","doi-asserted-by":"publisher","DOI":"10.1177\/089198870101400211"},{"key":"2023041303342861000_28.41.10422.13","first-page":"37","article-title":"Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression","volume":"55","author":"Deutch","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"2023041303342861000_28.41.10422.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01737-5"},{"key":"2023041303342861000_28.41.10422.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01059-1"},{"key":"2023041303342861000_28.41.10422.16","first-page":"33","article-title":"Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry","volume":"55","author":"Fibiger","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"2023041303342861000_28.41.10422.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.261583798"},{"key":"2023041303342861000_28.41.10422.18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"7","author":"Geyer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2023041303342861000_28.41.10422.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"2023041303342861000_28.41.10422.20","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.117093"},{"key":"2023041303342861000_28.41.10422.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401402"},{"key":"2023041303342861000_28.41.10422.22","first-page":"S116","article-title":"TBPB is a highly selective M1 allosteric muscarinic receptor agonist in vitro and produces robust antipsychotic-like effects in vivo","volume":"31","author":"Jones","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2023041303342861000_28.41.10422.23","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890150302"},{"key":"2023041303342861000_28.41.10422.24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300836"},{"key":"2023041303342861000_28.41.10422.25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301108"},{"key":"2023041303342861000_28.41.10422.26","first-page":"S26","article-title":"Muscarinic receptor activation for the treatment of schizophrenia","volume":"31","author":"Kinney","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2023041303342861000_28.41.10422.27","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J Neurosci"},{"key":"2023041303342861000_28.41.10422.28","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199609000-00008"},{"key":"2023041303342861000_28.41.10422.29","doi-asserted-by":"publisher","DOI":"10.2174\/1568007023339544"},{"key":"2023041303342861000_28.41.10422.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.19.11465"},{"key":"2023041303342861000_28.41.10422.31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(25)10792-1","article-title":"The behavioral pharmacology of olanzapine, a novel \u201catypical\u201d antipsychotic agent","volume":"262","author":"Moore","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"2023041303342861000_28.41.10422.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00251-2"},{"key":"2023041303342861000_28.41.10422.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01017-9"},{"key":"2023041303342861000_28.41.10422.34","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800303"},{"key":"2023041303342861000_28.41.10422.35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/mol.105.016139","article-title":"A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators","volume":"68","author":"Rodriguez","year":"2005","journal-title":"Mol Pharmacol"},{"key":"2023041303342861000_28.41.10422.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00594-3"},{"key":"2023041303342861000_28.41.10422.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(99)00138-3"},{"key":"2023041303342861000_28.41.10422.38","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.06091591"},{"key":"2023041303342861000_28.41.10422.39","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2007.55"},{"key":"2023041303342861000_28.41.10422.40","doi-asserted-by":"publisher","DOI":"10.1124\/mol.61.6.1297"},{"key":"2023041303342861000_28.41.10422.41","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.024901"},{"key":"2023041303342861000_28.41.10422.42","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2007.032.07.1116862"},{"key":"2023041303342861000_28.41.10422.43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3565(24)29291-0","article-title":"The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat","volume":"299","author":"Stanhope","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"2023041303342861000_28.41.10422.44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835612100"},{"key":"2023041303342861000_28.41.10422.45","unstructured":"Tantawy MN Peterson TE Jones C Baldwin RM Ansari M Kessler RM (2007) the 54th Annual Meeting of the Society of Nuclear Medicine (June 2\u20136, Washington, DC), Feasibility of determining [18F]Fallypride binding potential with delayed scans. Presented at."},{"key":"2023041303342861000_28.41.10422.46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMra055549","article-title":"Dystonia","volume":"335","author":"Tarsy","year":"2006","journal-title":"N Engl J Med"},{"key":"2023041303342861000_28.41.10422.47","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022888332221"},{"key":"2023041303342861000_28.41.10422.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1940-5"},{"key":"2023041303342861000_28.41.10422.49","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051001"},{"key":"2023041303342861000_28.41.10422.50","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1\u2013M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J Neurosci"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1850-08.2008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T16:14:21Z","timestamp":1738426461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.1850-08.2008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,8]]},"references-count":50,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2008,10,8]]},"published-print":{"date-parts":[[2008,10,8]]}},"alternative-id":["10.1523\/JNEUROSCI.1850-08.2008"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.1850-08.2008","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,8]]}}}